Physician profile
Joshua Morgan
NPI 1336689421
$2,644.74
in general payments reported to CMS, 2019-2025
10 companies · $230 in 2025
The $230 reported for 2025 was more than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $252 · 2023: $198 · 2024: $1,965 · 2025: $230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,664 · Food and Beverage: $729.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,663.88 |
| Food and Beverage | $729.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Invictus Surgical Incorporated | $1,202.67 | 2024 | |
| Arthrex, INC. | $650.30 | 2024 | |
| Depuy Synthes Sales INC. | $192.48 | 2024-2025 | Na |
| Si-Bone, INC. | $163.21 | 2023 | |
| Bluewind Medical | $109.12 | 2025 | Revi |
| Pacira Pharmaceuticals Incorporated | $93.79 | 2021 | |
| Integra Lifesciences Corporation | $82.45 | 2021 | |
| Vertos Medical, INC. | $75.27 | 2021 | |
| Curonix LLC | $40.43 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Stryker Corporation | $35.02 | 2023 | Hoffmann |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Morgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.